This inventor holds 3 USPTO granted patents. Top assignee: Rutgers, The State University of New Jersey. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lake Hiawatha, NJ (US) (2017)
- Branchburg, NJ (US) (2017 - 2019)
Company Filing History:
Years Active: 2017-2019
Title: Venkata S Neti: Innovator in Therapeutic Drug Development
Introduction
Venkata S Neti is a prominent inventor based in Branchburg, NJ (US). She has made significant contributions to the field of therapeutic drug development, particularly in the treatment of cancer. With a total of 3 patents, her work focuses on overcoming the limitations of traditional therapeutic methods.
Latest Patents
Venkata S Neti's latest patents include innovative methods aimed at enhancing the efficacy of radiopharmaceuticals and chemotherapy drugs. One of her notable patents describes a method for predicting the response of an individual patient's cells to therapeutic interventions. This method involves measuring the cellular incorporation of therapeutic agents on a cell-by-cell basis, allowing for the identification of an optimal cocktail of agents for disease treatment. Another patent outlines a method for determining the optimal amounts of these agents to administer, based on the saturation levels in the patient's cells. These advancements represent a significant leap forward in personalized medicine.
Career Highlights
Venkata S Neti is affiliated with Rutgers, the State University of New Jersey, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.
Collaborations
Some of her notable coworkers include John M Akudugu and Roger W Howell, who have collaborated with her on various projects aimed at advancing therapeutic methodologies.
Conclusion
Venkata S Neti's innovative approaches to drug development highlight her commitment to improving cancer treatment through personalized medicine. Her contributions are paving the way for more effective therapeutic strategies in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
